OnQuality Pharmaceuticals to Have Two Abstracts Published in the 2022 ASCO Annual Meeting Proceedings
- Friday, May 27, 2022, 7:04
- Finance
- Add a comment
– Preclinical data demonstrating OQL051, a gut-restricted CDK4/6 inhibitor, as a potential prophylactic treatment for chemotherapy-induced diarrhea – Survey of academic and community oncologists studying the prevention and treatment patterns of papulopustular, acneiform skin toxicity…
About the Author
adminasapcorp has written 41555 stories on this site.